Ya-hong Hu

机构：Xiamen University

发表论文 5 篇 · 总被引 183 次 · h-index 5

代表论文

• Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition (2021 · Cancer Immunology Research · 被引 65)
• Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer (2022 · Nucleic Acids Research · 被引 63)
• BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma (2021 · Molecular Therapy · 被引 34)
• PILRα on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunity (2025 · Nature Cancer · 被引 10)
• A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19 (2023 · Cellular and Molecular Immunology · 被引 10)